AI is becoming useful in healthcare for things like clinical research, diagnostics, treatment planning, and managing workflows. But healthcare data is very sensitive. It includes patient histories, treatments, lab results, and billing information, so protecting privacy is important. Data breaches can make patients lose trust and can cause big fines under laws like HIPAA.
Studies show that one big problem in using AI in healthcare is keeping data private when working with large amounts of information. Many healthcare providers do not want to share data because of concerns about security and following the rules. Also, medical records are often not in the same format, and ethical issues make using AI harder.
One growing solution is privacy-preserving AI. These technologies let people analyze and work with data while keeping sensitive information safe.
Federated Learning (FL) trains AI models directly on local data, such as in hospital or clinic databases. It does this without sending patient data to a central server. Instead, the model learns from data where it is stored and only shares updates or model parameters with a main server. This lowers privacy risks.
For U.S. medical practices, this is useful because they can work together to build AI models while following HIPAA rules, since patient data never leaves their location.
But Federated Learning still faces some problems:
Still, FL is one of the few methods that support large-scale AI development in healthcare while respecting privacy laws.
Hybrid methods mix Federated Learning with other protections like encryption and data masking. These methods protect patient information during AI training and data processing. They may use secure multiparty computation or homomorphic encryption to keep data safe from unauthorized access.
These approaches are important because hospitals, clinics, and labs in the U.S. often store patient records in many different formats and systems.
Healthcare providers in the U.S. must follow rules like HIPAA and other state laws. These laws say how patient data should be shared, stored, and transmitted.
Here are some practices for using AI while meeting these rules:
Privacy-enhancing AI has benefits, but some challenges slow its wider use:
Research continues to improve methods, privacy tech, and data standards to allow safer AI models in healthcare.
AI is also useful for automating healthcare administrative tasks. In the U.S., administrators and IT managers can use AI to handle front-office tasks like scheduling, billing questions, and answering phone calls. This can cut down work and costs.
An example is AI-based phone automation, like systems from companies such as Simbo AI. These use natural language processing and strict privacy rules to manage calls, make appointments, and answer common questions without risking patient data.
Benefits of AI for workflow automation include:
Using AI automation along with privacy technologies helps healthcare workers improve efficiency and stay compliant.
Some organizations show how AI can meet privacy rules and stay useful:
These examples show how healthcare technology is working to balance AI innovation with data protection.
Administrators, owners, and IT managers in healthcare who want to use AI while following U.S. laws should consider these steps:
Using privacy-enhancing AI in U.S. healthcare means balancing powerful data analysis with following strict privacy laws. Methods like Federated Learning, hybrid algorithms, and workflow automation help medical practices gain useful insights and work more efficiently without risking patient privacy.
As challenges like data differences, communication costs, and legal rules get solved, these AI methods will likely be used more. Healthcare leaders and IT managers should stay updated about AI changes, work with trusted vendors, and focus on compliance to safely use AI in healthcare.
IQVIA’s new AI agents, developed with NVIDIA technology, are designed to enhance workflows and accelerate insights specifically for life sciences, helping streamline clinical research, simplify operations, and improve patient outcomes across various stages like target identification, clinical data review, literature review, and healthcare professional engagement.
IQVIA uses NVIDIA’s NIM Agent Blueprints for rapid development, NeMo Customizer for fine-tuning AI models, and NeMo Guardrails to ensure safe deployment. This collaboration enables customized agentic AI workflows that meet the unique needs of the life sciences industry.
Agentic AI provides precision, efficiency, and speed in critical workflows such as planning clinical trials, reviewing literature, and commercial launches, allowing life sciences companies to gain actionable insights faster and improve decision-making.
Use cases include target identification for drug development, clinical data review, literature review, market assessment, and enhanced engagement with healthcare professionals (HCPs), which collectively improve research and commercial processes.
IQVIA integrates deep life sciences and healthcare domain expertise with advanced AI technology to deliver highly relevant, accurate, and compliant AI-powered solutions tailored to the industry’s complex workflows.
IQVIA employs a variety of privacy-enhancing technologies and safeguards, adhering to stringent regulatory requirements to protect individual patient privacy while enabling large-scale data analysis for improved health outcomes.
Healthcare-grade AI® by IQVIA is specifically built for the precision, speed, trust, and regulatory compliance needed in life sciences, facilitating high-quality actionable insights throughout the clinical asset lifecycle.
AI agents accelerate clinical trials by efficiently sifting through vast literature, identifying relevant data, coordinating workflow stages from discovery to commercial application, and reducing time-consuming manual tasks.
The partnership accelerates the development of customized foundation models and agentic AI workflows to enhance clinical development and access to new treatments, pushing the future of life sciences research and commercialization.
IQVIA TechIQ 2025, a two-day conference in London, will feature thought leaders including NVIDIA, exploring strategic approaches to AI implementation in life sciences to navigate the evolving frontier of healthcare AI applications.